# FDA Inspection 1112434 - Biomat USA, Inc. - December 05, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f42e6466-edbc-4500-ac92-14bc8d3afb8f
Source feed: FDA_Inspections

> FDA Inspection 1112434 for Biomat USA, Inc. on December 05, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1112434
- Company Name: Biomat USA, Inc.
- Inspection Date: 2019-12-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1046158 - 2018-03-26](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ebb5239c-0391-4f90-ad53-0cbb5c222bc6)
- [FDA Inspection 958048 - 2016-02-04](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4456e8df-ad39-4f8e-8e3b-557fc21433cc)
- [FDA Inspection 869226 - 2014-03-06](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/9094e731-289b-4514-989a-8ac34462ae75)
- [FDA Inspection 755349 - 2011-11-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/10e7409d-6db6-48e3-be4f-967f903a3510)
- [FDA Inspection 635273 - 2009-12-14](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/6dcfaa2d-afe2-4dc7-b898-b6557f4519f6)

Company: https://www.keypedia.com/companies/biomat-usa-inc/33da25c1-b339-4132-90eb-d5c2498ff692

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d